Myhep all tablet
INR 6000INR 18000
In stock
Description
buy 7409966555
MyHep All Tablet contains Sofosbuvir 400 mg + Velpatasvir 100 mg, a combination of two direct-acting antiviral medicines used to treat chronic Hepatitis C (HCV) infection. It is marketed by Mylan Pharmaceuticals Pvt. Ltd., a Viatris company.
Key Information
Composition: Sofosbuvir 400 mg + Velpatasvir 100 mg
Drug class: Direct-acting antiviral (DAA)
Main use: Chronic Hepatitis C infection
Manufacturer/Marketer: Mylan Pharmaceuticals Pvt. Ltd.
Dosage form: Oral tablet
Common pack: 28 tablets
How it works:
Sofosbuvir and velpatasvir target different proteins involved in HCV replication. Together, they suppress viral replication and help the body clear the infection. The combination has activity against major HCV genotypes.
